Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 61 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: ES031822, ES028335, ES028263
NIEHS NIH HHS
Grant: R01 ES028263
NIEHS NIH HHS
Grant: R01 ES031822
NIEHS NIH HHS
Grant: R01 ES028335
National Institutes of Health
Grant: 5R01ES031822-06
Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells
National Institutes of Health
Grant: 5R01ES028335-02
Arsenic-induced miRNA-199 and miRNA-214 deplete mitochondrial DNA for the generation of cancer stem-like cells
National Institutes of Health
Grant: 5R01ES028263-04
Reduced reactive oxygen species and oxidative phosphorylation in arsenic-induced cancer stem cells
Fields of Study
Keywords
Sustainable Development Goals